// App-Quantinova.ai

644 : Outcomes of patients (pts) with BRAF mutated (BRAF MT) Colorectal Cancer (CRC): The Royal Marsden Experience.

Researchers

Presenter

  • Hamzeh Kayhanian

Principal Investigators

  • Emily Goode

  • Joo Ern Ang

  • David Gonzalez de Castro

  • Francesco Sclafani

  • Ann Petruckevitch

  • Sheela Rao

  • David J. Watkins

  • Marco Gerlinger

  • David Cunningham

  • Ian Chau

  • Naureen Starling

Medical Centers

  • The Royal Marsden Hospital, London, United Kingdom

  • Royal Marsden Hospital, Surrey, United Kingdom

  • The Royal Marsden Hospital NHS Foundation Trust, London & Surrey, United Kingdom

  • The Royal Marsden Hospital NHS Foundation Trust, London & Surrey, United Kingdom

  • The Royal Marsden Hospital NHS Foundation Trust, London & Surrey, United Kingdom

  • Translational Oncogenomics Lab, Institute of Cancer Research, London, United Kingdom

  • Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Gastroenterology (GU)

Disease

  • Colorectal Cancer

Biomarkers

  • B-Raf proto-oncogene, serine/threonine kinase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved